Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Minty_33on Apr 20, 2022 7:51pm
105 Views
Post# 34618540

RE:CZO is a biotech company

RE:CZO is a biotech companySeptember 30, 2005........"Ceapro has also discovered that beta glucan can be used as atransdermal delivery system to feed drugs and other compounds into theskin. This development may lead to new and better ways of deliveringsuch medicines as antihistamines and pain relievers".

Almost 17 years later Ceapro has not commercialized 1 product. I'll say it again not 1 product. They haven't even been able to sign a JV agreement, why? Not 1 lousy agreement that can monetize their supposed technology. All the pier reviewed papers, all the world changing new chemical complexes, Billion dollar markets, Salon 360 award for best raw material in 2016, they cannot monetize! $600 K plus salary to a distributor of grain byproducts whilst the share price is down 80% from 2016 and 50% from their last private placement. Was geht ab? Nicht so viel. Ni!
<< Previous
Bullboard Posts
Next >>